Avastin to Remain Leader in the Colorectal Cancer Drugs Market | GlobalData Plc - Press Release
LONDON, July 14, 2022 (GLOBE NEWSWIRE) -- The "Colorectal Cancer – Global Drug Forecast and Market Analysis to 2028" market research report offered by
Stay updated with breaking news from Staging Systems. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
LONDON, July 14, 2022 (GLOBE NEWSWIRE) -- The "Colorectal Cancer – Global Drug Forecast and Market Analysis to 2028" market research report offered by
DUBLIN--(BUSINESS WIRE)--The "Hypoglycemia - Global Drug Forecast and Market Analysis to 2030" report has been added to ResearchAndMarkets.com's offering.This report will focus on diabetic hypoglycemia, and post-bariatric surgery hypoglycemia (PBH). There is currently no approved treatment for PBH.The therapeutic ma...
ResearchAndMarkets.com’s offering. Sales for the NASH market to grow from $144.4M in 2019 to $27.2B in 2029 at a Compound Annual Growth Rate (CAGR) of 68.8% across the 7MM. At the end of 2029, the US will contribute around 94.3% of global sales, while the 5EU and Japan will account for around 4.5% and 1.2% of sales, respectively. Non-alcoholic steatohepatitis (NASH) is a common, often clinically silent liver disease characterized by the presence of steatosis (fatty liver), in addition to liver inflammation and damage. Unlike alcoholic liver disease, NASH occurs in those who drink little or ...